| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/21/2005 | CN1671711A Calcitonin gene related peptide receptor antagonists |
| 09/21/2005 | CN1219515C In vivo stain compounds and methods of use to identify dysplastic tissue |
| 09/20/2005 | US6946547 Via immunoassay; low cross-reactivity with ephedrine and other compounds; antibody produced by a methylene dioxyphenyl derivative of agiven structure |
| 09/20/2005 | US6946259 Compositions and methods for treating cells having double minute DNA |
| 09/20/2005 | CA2084582C Process for the production of mono-n-substituted tetraaza macrocycles |
| 09/15/2005 | WO2005084718A1 Method for producing nano-bubble |
| 09/15/2005 | WO2005084716A2 Phospholipid analogs for diagnosis and treatment of cancer |
| 09/15/2005 | WO2005084715A2 Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy |
| 09/15/2005 | WO2005084710A2 Nanocell drug delivery system |
| 09/15/2005 | WO2005084527A1 Joint-diagnostic in vivo & in vitro apparatus |
| 09/15/2005 | WO2005084429A1 Method of constructing animal having cancer cells transplanted thereinto |
| 09/15/2005 | WO2005084361A2 Multi-component biological transport systems |
| 09/15/2005 | WO2003000844A3 Protein modification and maintenance molecules |
| 09/15/2005 | US20050204412 Artery- and vein-specific proteins and uses therefor |
| 09/15/2005 | US20050203356 Joint-diagnostic in vivo & in vitro apparatus |
| 09/15/2005 | US20050203292 Nanoparticulate probe for in vivo monitoring of tissue oxygenation |
| 09/15/2005 | US20050203013 Administering endostatin, thrombospondin; angiogenesis inhibitors; anticancert agents; antidiabetic agents; nephropathy; antiallergens; prevent leakage from blood vessels; vision defects; psoriasis |
| 09/15/2005 | US20050202529 Humanised antibodies |
| 09/15/2005 | US20050202406 Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems |
| 09/15/2005 | US20050202076 Stabilization, homogenizing, sterile filtration, dehydration, reconstitution, ultrafiltration; storage stability; taxanes |
| 09/15/2005 | US20050201943 Magnetic resonance imaging using contrast agents bioactivated by enzymatic cleavage |
| 09/15/2005 | US20050201942 Preparing microbubble-generating carbohydrate microparticles with an incorporated surfactant by freeze drying; enhanced echocardiographic imaging |
| 09/15/2005 | US20050201941 Magnetic nanoparticle |
| 09/15/2005 | US20050201940 Diagnostics and radiotherapy; magnetic resonance imaging (MRI); treatment of a tumor |
| 09/15/2005 | US20050201939 Dye-peptide complex; supplying to tumor cells; for diagnostic imaging and therapy; biocompatibility |
| 09/15/2005 | US20050201938 Method for selectively inhibiting ghrelin action |
| 09/15/2005 | US20050201937 Creation of a gradient of isotope enrichment; ability to measure a multiplicity of isotope enrichments simultaneously |
| 09/15/2005 | US20050201936 Adenoviral gene therapy; examination of the ability of various replicative, non-replicative and conditionally-replicative adenovirus vectors to treat cancer |
| 09/15/2005 | US20050201931 LAT1 transporters expressed in blood brain barrier cells |
| 09/15/2005 | US20050201930 Ultrasonic contrast agents; aqueous suspension |
| 09/15/2005 | US20050201614 3-D in-vivo imaging and topography using structured light |
| 09/15/2005 | DE102004002639A1 Verfahren zur Anreicherung von hyperpolarisierten Atomkernen und Vorrichtung zur Durchführung des Verfahrens A process for enrichment of the hyperpolarized nuclei and apparatus for carrying out the method |
| 09/15/2005 | CA2558399A1 Partially loaded antibodies and methods of their conjugation |
| 09/15/2005 | CA2558379A1 Multi-component biological transport systems |
| 09/15/2005 | CA2558263A1 Nanocell drug delivery system |
| 09/15/2005 | CA2557698A1 Phospholipid analogs as diapeutic* agents and methods therefor |
| 09/15/2005 | CA2529752A1 Polypeptide transduction and fusogenic peptides |
| 09/14/2005 | EP1573314A2 Transgenic mice expressing human cd20 |
| 09/14/2005 | EP1573313A2 Transgenic mice expressing human cd20 and/or cd16 |
| 09/14/2005 | EP1573044A2 Serum biomarkers in lung cancer |
| 09/14/2005 | EP1572875A2 Receptors and membrane-associated proteins |
| 09/14/2005 | EP1572724A2 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 09/14/2005 | EP1572639A1 Integrin targeted imaging agents |
| 09/14/2005 | EP1572246A2 Novel compositions of magnetic particles covered with gem-bisphosphonate derivatives |
| 09/14/2005 | EP1572245A1 Magnetic resonance imaging method and compounds for use in the method |
| 09/14/2005 | EP1572077A2 Uses of monoclonal antibody 8h9 |
| 09/14/2005 | EP1289414B1 Combined impedance imaging and mammography |
| 09/14/2005 | EP1284958B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives |
| 09/14/2005 | EP0920277B1 Laser opto-acoustic imaging system |
| 09/14/2005 | CN1668758A Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 09/14/2005 | CN1668339A Steroid conjugates, preparation thereof and the use thereof |
| 09/14/2005 | CN1668338A Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi |
| 09/14/2005 | CN1218983C Folic acid-polydiol compound and its medicinal composition |
| 09/14/2005 | CN1218752C Compound function supermicro magnetic carrier particle and its preparing method |
| 09/13/2005 | US6944493 Indocyanine green (ICG) compositions and related methods of use |
| 09/13/2005 | US6943269 Contrast media for angiography |
| 09/13/2005 | US6942614 Method and system for use in treating a patient with an anticoagulant to optimize therapy and prevent an adverse drug response |
| 09/13/2005 | US6942467 UHV compatible lead through, device and procedure for highly effective production of nuclear spin polarized 3He at high polarization |
| 09/13/2005 | CA2102186C Nanoparticles having a prolonged reticulo-endothelial system capture rate |
| 09/09/2005 | WO2005082424A1 Biological assay |
| 09/09/2005 | WO2005082423A2 Serum albumin conjugated to fluorescent substances for imaging |
| 09/09/2005 | WO2004112763A3 Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure |
| 09/09/2005 | WO2004096998A3 Nanoparticular tumor targeting and therapy |
| 09/09/2005 | CA2557085A1 Biological assay |
| 09/09/2005 | CA2555702A1 Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity |
| 09/09/2005 | CA2460898A1 Apparatus and method for combining in vivo and in vitro testing |
| 09/08/2005 | US20050196735 Memory capacity tests and uses thereof |
| 09/08/2005 | US20050196426 A polymeric hydrogel material that permits cellular ingrowth and has controlled rate of expansion optimized for delivery through microcatheter or catheter without need for a nonaqueous solvent or coating |
| 09/08/2005 | US20050196343 Degradable nanoparticles |
| 09/08/2005 | US20050196342 Contrast agents |
| 09/08/2005 | US20050196341 Kit of parts for treating urinary incontinence in mammals |
| 09/08/2005 | US20050196339 For detecting and locating recurrence of cancer, radiation and drug resistance, and/or metastasis |
| 09/08/2005 | US20050195943 Method of forming subtraction images |
| 09/07/2005 | EP1569677A1 Liposomal composition comprising haptotactic peptides |
| 09/07/2005 | EP1165087B1 In vivo stain compounds and methods of use to identify dysplastic tissue |
| 09/07/2005 | EP0744962B2 Method of storage of ultrasonic gas suspensions |
| 09/07/2005 | CN1665546A Medicinal formulation in particular for treating herniated invertebral discs |
| 09/07/2005 | CN1665545A Compound ablation mixture and its use in preparation of drugs for treating tumors |
| 09/07/2005 | CN1665543A Fusions of cytokines and tumor targeting proteins |
| 09/07/2005 | CN1217701C Near infrared fluorescent contrast agent and fluorescence imaging |
| 09/06/2005 | US6939532 Versatile hydrophilic dyes |
| 09/06/2005 | US6939531 Surrounding a first gas and a second gas with a membrane to form stabilized microbubbles in said liquid, where neither of the gases are water vapor; e.g. perfluoropropane with modifier gas of air and membrane of albumin |
| 09/06/2005 | US6939530 Preparation of further diagnostic agents |
| 09/01/2005 | WO2005080032A1 Process for producing iron colloid, and iron-colloid-bearing polymer micelle |
| 09/01/2005 | WO2005079877A1 Wound dressings comprising a protein polymer and a polyfunctional spacer |
| 09/01/2005 | WO2005079863A1 Contrast medium for thrombus formation |
| 09/01/2005 | WO2005079391A2 Contrast agents for myocardial perfusion imaging |
| 09/01/2005 | WO2005079384A2 Expandable gastric retention device |
| 09/01/2005 | WO2005067388A3 Perturbed membrane-binding compounds and methods of using the same |
| 09/01/2005 | WO2005016112A3 Post-biopsy cavity treatment implants and methods |
| 09/01/2005 | WO2004073656A9 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 09/01/2005 | WO2002083873A3 Enzymes |
| 09/01/2005 | US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 09/01/2005 | US20050191248 such as silk or bleomycin; treatment for a dental condition such as periodontal disease |
| 09/01/2005 | US20050191243 Based on CEST procedure for determination of a physical or chemical parameter of diagnostic interest which includes the administration of the responsive agent |
| 09/01/2005 | US20050191242 Modulating skin pigmentation; identifying an agent that modulates skin pigmentation and administering it |
| 09/01/2005 | US20050191238 imaging myocardial perfusion, comprising administering to a patient a contrast agent which comprises a compound that binds MC-1, and an imaging moiety, and scanning the patient using diagnostic imaging. |
| 09/01/2005 | DE19964224B4 Pharmazeutische Mittel enthaltend Calcium-Komplex von Pharmaceutical preparations containing calcium complex of [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.N]-6,9-bis[(carboxy-.kappa.O)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-yl-säure-.kappa.N6,.kappa.N9,.kappa.011]1-oxidato(6-)]-, tetrahydrogen (MS-325) und dessen Salze sowie Verfahren zur Herstellung der Mittel tetra hydrogen (MS-325) and salts thereof as well as methods for preparing the compositions |
| 09/01/2005 | DE102004038076A1 Use of annexin A3, or other proteins, as diagnostic markers for cancer, especially of the prostate, also use of modulators of these markers for treating cancer |
| 09/01/2005 | DE102004008459A1 Implant, useful as stents, comprises a fabric and at least a radiopaque marker, which passes in a direction along the implant |